Lith-O-Asp
Lith-O-Asp Basic information
- Product Name:
- Lith-O-Asp
- Synonyms:
-
- Lith-O-Asp
- Cholan-24-oic acid, 3-[(2S)-2-amino-3-carboxy-1-oxopropoxy]-, (3α,5β)-
- LithOAsp,Lith O Asp
- CAS:
- 881179-02-8
- MF:
- C28H45NO6
- MW:
- 491.67
- Mol File:
- 881179-02-8.mol
Lith-O-Asp Chemical Properties
- Melting point:
- 208-209 °C
- Boiling point:
- 635.0±45.0 °C(Predicted)
- Density
- 1.19±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO : ≥ 106 mg/mL (215.60 mM)
- pka
- 3.43±0.19(Predicted)
- form
- Solid
- color
- White to off-white
Lith-O-Asp Usage And Synthesis
Uses
Lith-O-Asp is a sialytransferase (ST) inhibitor, with IC50s of 12-37 μM.
in vivo
A significant amount of secondary metastatic cancer cells are observed in lung tissues of DMSO control mice detected using IVIS in vivo imaging system after 26 days of fat pad inoculation. However, Lith-O-Asp–treated mice show fewer lung metastases. All DMSO-treated mice confirm secondary lung metastasis, but only 3 of 8 Lith-O-Asp-treated mice show lung metastasis. Average tumor nodules per mouse are 11±9 nodules in DMSO-treated group, and 2±4 nodules in Lith-O-Asp-treated group. Additionally, significantly stronger 4T1-Luc illumination signals are shown in control mice than in those injected with Lith-O-Asp-treated cancer cells on days 7 and 9[1].
References
[1] Chen JY, et al. A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways. Cancer Res. 2011 Jan 15;71(2):473-83. DOI:10.1158/0008-5472.CAN-10-1303
Lith-O-AspSupplier
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Tel
- 18818260767
- sales@chemegen.com
- Tel
- 010-60605840 15801484223;
- psaitong@jm-bio.com
- Tel
- 4008200310
- marketing@tsbiochem.com
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com